(Bloomberg) — Germany plans to buy 105 additional Leopard 2 A8 battle tanks as part of the ruling coalition’s multi-billion euro program to modernize the armed forces triggered by Russia’s full-scale invasion of Ukraine. Most Read from Bloomberg Defense Minister Boris Pistorius has asked lawmakers to approve the purchase from Franco-German manufacturer KNDS in a […]
Grant Cardone’s Prophecy Rings True: U.S. Mortgage Drop Bolsters Warning On Short-Term Rentals U.S. homebuyers took out 40% fewer mortgages in 2023 than they did a year earlier — a figure that appears to be proving real estate mogul Grant Cardone’s warning to avoid short-term rental properties is correct. Cardone told his followers on X […]
By Luc Cohen NEW YORK (Reuters) – Donald Trump‘s lawyers at his New York criminal trial have portrayed his estranged former fixer Michael Cohen as a liar and Trump-hater who acted alone to pay off a porn star, but legal experts say prosecutors have largely backed up his testimony with the accounts of others, phone […]
WASHINGTON — The Supreme Court on Tuesday avoided another contentious debate over race and education by turning away a challenge to an admissions policy aimed at encouraging diversity at a Virginia high school. The high court’s decision not to intervene in the case comes just months after the conservative court ended the consideration of race […]
WASHINGTON (AP) — President Joe Biden is dispatching two of his senior-most White House advisers to bolster his Delaware-based reelection campaign as his focus shifts to the general election in November. The moves of his deputy chief of staff Jen O’Malley Dillon, his 2020 campaign manager, and senior adviser Mike Donilon to the campaign had […]
AstraZeneca Plc (NASDAQ: AZN) has agreed to acquire Gracell Biotechnologies Inc (NASDAQ: GRCL), further strengthening AstraZeneca’s cell therapy portfolio. The deal value is $2.00/share (equivalent to $10/ADS ADS of Gracell) plus a non-tradable contingent value right of $0.30/share (equivalent to $1.50/ADS of Gracell) in cash. The proposed acquisition will enrich AstraZeneca’s growing pipeline of cell therapies with GC012F, a […]